Federal Register / Vol. 60, No. 35 / Wednesday, February 22, 1995 / Notices 9853

* Applicants who wish to use express mail or

courier service should change the zip code to

20817–7710.

Dated: February 15, 1995.

Susan K. Feldman,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 95–4242 Filed 2–21–95; 8:45 am]

BILLING CODE 4140–01–M

National Institutes of Health

National Institute of Mental Health;

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings of the National Institute of

Mental Health Initial Review Group:

Agenda/Purpose: To review and

evaluate grant applications

Committee Name: Child

Psychopathology and Treatment

Review Committee

Date: March 1–3, 1995

Time: 9 a.m.

Place: Wyndham Brystol Hotel, 2430

Pennsylvania Avenue NW.,

Washington, DC 20037

Contact Person: Bernice R. Cherry,

Grants Technical Assistant, Parklawn

Building, Room 9C–18, 5600 Fishers

Lane, Rockville, MD 20857,

Telephone: 301, 443–1367

Committee Name: Mental Health AIDS

and Immunology Review

Committee—1

Date: March 2–3, 1995

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD

20814

Contact Person: Regina M. Thomas,

Grants Technical Assistant, Parklawn

Building, Room 9C–26, 5600 Fishers

Lane, Rockville, MD 20857,

Telephone: 301, 443–6470

Committee Name: Epidemiology and

Genetics Review Committee

Date: March 5–7, 1995

Time: 9 a.m.

Place: Embassy Suites at Chevy Chase,

4300 Military Road, NW.,

Washington, DC 20015

Contact Person: Bernice R. Cherry,

Grants Technical Assistant, Parklawn

Building, Room 9C–18, 5600 Fishers

Lane, Rockville, MD 20857,

Telephone: 301, 443–1367

Committee Name: Mental Health AIDS

and Immunology Review

Committee—2

Date: March 6–7, 1995

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD

20814

Contact Person: Rehana A. Chowdhury,

Grants Technical Assistant, Parklawn

Building, Room 9C–26, 5600 Fishers

Lane, Rockville, MD 20857,

Telephone: 301, 443–6470

The meetings will be closed in

accordance with the provisions set forth

in sec. 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals with the applications and/or

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

This notice is being published less

than fifteen days prior to the meeting

due to the urgent need to meet timing

limitations imposed by the intramural

research review cycle.

(Catalog of Federal Domestic Assistance

Program Numbers 93.126, Small Business

Innovation Research; 93.176, ADAMHA

Small Instrumentation Program Grants;

93.242, Mental Health Research Grants;

93.281, Mental Research Scientist

Development Award and Research Scientists

Development Award for Clinicians; 93.282,

Mental Health Research Service Awards for

Research Training; and 93.921, ADAMHA

Science Education Partnership Award.

Dated: February 15, 1995.

Susan K. Feldman,

Committee Management Officer, National

Institutes of Health.

[FR Doc. 95–4243 Filed 2–21–95; 8:45 am]

BILLING CODE 4140–01–M

Substance Abuse and Mental Health

Services Administration

Fiscal Year (FY) 1995 Notices of

Funding Availability

AGENCY: Substance Abuse and Mental

Health Services Administration

(SAMHSA), HHS.

ACTION: Correction notice.

SUMMARY: Public notice was given in the

Federal Register on February 10, 1995,

Volume 60, No. 28, pages 7980–7984, of

the funding opportunities for grants and

cooperative agreements from the Center

for Substance Abuse Prevention (CSAP)

during FY 1995. On page 7983, under

the Eligible Applicants section of 4.1.3

Community Prevention Coalitions

Demonstration Grant Program, a

statement was included that ‘‘the

applicant must be part of an existing

community partnership and must be

designated to act on behalf of the larger

coalition of multiple partnerships

proposed in the grant application.’’

The requirement that the applicant

must be part of an existing partnership

has been deleted, and the revised

Eligible Applicants section now states

that ‘‘the applicant must be designated

to act on behalf of the larger evolving

coalition of multiple partnerships

proposed in the grant application.’’

Public notice was also given in the

Federal Register on: January 4, 1995,

Volume 60, No. 2, pages 474–478;

January 30, 1995, Volume 60, No. 19,

pages 5688–5691; and February 10,

1995, Volume 60, No. 28, pages 7977–

7984; of the availability of funds from

the SAMHSA Centers—Center for

Mental Health Services, Center for

Substance Abuse Prevention, and Center

for Substance Abuse Treatment—for

grant and cooperative agreement

activities during FY 1995.

These notices specified that

competing grant and cooperative

agreement applications should be

submitted to the Division of Research

Grants, NIH, Westwood Building-Room

240, 5333 Westbard Avenue, Bethesda,

MD 20892.

The mailing address for the Division

of Research Grants, NIH, is being

changed. Effective April 21, 1995, all

competing SAMHSA applications must

be sent to: Division of Research Grants,

National Institutes of Health, 6701

Rockledge Drive MSC–7710, Bethesda,

MD 20892–7710.*

Dated: February 16, 1995.

Richard Kopanda,

Acting Executive Officer, SAMHSA.

[FR Doc. 95–4323 Filed 2–21–95; 8:45 am]

BILLING CODE 4162–20–P

Cooperative Agreement with the

Pennsylvania Department of Health

AGENCY: Center For Substance Abuse

Treatment, Substance Abuse and Mental

Health Services Administration

(SAMHSA), HHS.

ACTION: Notice of a planned single

source, cooperative agreement award to

support further development and

continuation of a model comprehensive

substance abuse treatment

demonstration program for the City of

Philadelphia.

SUMMARY: The Center for Substance

Abuse Treatment (CSAT), SAMHSA, is

publishing this notice to provide

information to the public regarding a

planned single source competing

continuation award to the Pennsylvania

Department of Health for the further

development and operation of a model

substance abuse treatment

demonstration program. The current

‘‘Target Cities’’ project period will be